Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESRRA | P11474 | 5/20 | 0.50 |
| ▸ | NR1H4 | Q96RI1 | 7/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | ATM | Q13315 | 2/20 | 0.39 |
| ▸ | THRA | P10827 | 1/20 | 0.38 |
| ▸ | THRB | P10828 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 2/20 | 0.37 |
| ▸ | XBP1 | P17861 | 1/20 | 0.37 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6543994 | 0.91 | ESRRA (0.39) | ESRRANR1H4ALDH1A1THRATHRB | |
| SCHEMBL6544711 | 0.90 | ESRRA (0.39) | ESRRANR1H4ALDH1A1ATMTHRA | |
| SCHEMBL6543660 | 0.89 | ESRRA (0.37) | ESRRANR1H4THRATHRB | |
| SCHEMBL6544374 | 0.85 | PARP10 (0.38) | ESRRA | |
| SCHEMBL27939698 | 0.84 | KMT2A (0.37) | ESRRAALDH1A1MAPTL3MBTL1 | |
| SCHEMBL6543619 | 0.83 | HDAC3 (0.39) | THRATHRBPOLBMAPTNPSR1 | |
| SCHEMBL15930785 | 0.83 | ABL1 (0.35) | ESRRA | |
| SCHEMBL6544813 | 0.83 | ALDH1A1 (0.39) | ESRRANR1H4ALDH1A1GAA | |
| SCHEMBL6544248 | 0.83 | PARP10 (0.40) | ALDH1A1POLBL3MBTL1 | |
| SCHEMBL6543768 | 0.83 | MMP13 (0.43) | ALDH1A1POLBNPSR1L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1022272-B1 | SUBSTITUTED FUSED HETEROCYCLIC COMPOUNDS | SANKYO CO (JP) | 2004-05-26 | — | — | EP | disclosed |
| US-6432993-B1 | BENZIMIDAZOLE OR IMIDAZO(4,5-B)PYRIDINE DERIVATES; IMMUNOMODULATORS; ALDOSE REDUCTASE AND LIPOXYGENASE INHIBITORS; DIABETES; PREVENTS LIPID PEROXIDATION; ANTILIPEMIC, HYPOTENSIVE AGENTS | SANKYO COMPANY, LIMITED (JP) | 2002-08-13 | — | — | US | disclosed |
| EP-1022272-A1 | SUBSTITUTED FUSED HETEROCYCLIC COMPOUNDS | Sankyo Company Limited (JP) | 2000-07-26 | — | — | EP | disclosed |